Teva Pharma (TEVA) Tops Q4 EPS by 31c, Beats on Revenue; Offers FY26 Revenue Guidance
Go back to Teva Pharma (TEVA) Tops Q4 EPS by 31c, Beats on Revenue; Offers FY26 Revenue Guidance| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 32.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.20 | 52 Week High | $66.55 | |||
| Open | $32.20 | 52 Week Low | $37.82 | |||
| Day High | $32.20 | P/E | N/A | |||
| Day Low | $32.20 | EPS | $0.00 | |||
| Volume | 15,845 | |||||
